Skip to main content
. 2017 May 16;6:48. doi: 10.1186/s13756-017-0206-z

Table 1.

Collection dates, van-genotypes, MLST sequence types (all isolates) and antimicrobial resistance expression (only patient isolates) of VRE strains

Isolate no. Collection date van-genotype MLST- ST AMP SAM AX AMC PRL TPZ IPM CIP LEV TEC QD TGC LNZ F SXT CN-HLR S-HLR
P1 2015–03-01 vanA 203 r r r r r r r r r r s s s r r + +
P2 2015–03-18 vanB 192 r r r r r r r r r s s s s s r +
P3 2015–04-16 vanB 192 r r r r r r r r r s s s s s r +
P4 2015–04-26 vanA 117 r r r r r r r r r r s s s s r +
P5 2015–05-01 vanB 80 r r r r r r r r r s s s s s r
P6 2015–05-22 vanA 769 r r r r r r r r r r s s s s r +
P7 2015–05-22 vanB 192 r r r r r r r r r s s s s s r +
P8 2015–05-23 vanA 769 r r r r r r r r r r s s s s r +
P9 2015–05-23 vanB 117 r r r r r r r r r s s s s r r + +
P10 2015–05-23 vanA + vanB 17 r r r r r r r r r s s s s r r + +
P11 2015–05-23 vanB N/A r r r r r r r r r s s s s s r +
P12 2015–05-23 vanB 192 r r r r r r r r r s s s s s r
P13 2015–05-24 vanB N/A r r r r r r r r r s s s s s r +
P14 2015–05-25 vanA 769 r r r r r r r r r r s s s s r + +
P15 2015–05-28 vanA 203 r r r r r r r r r r s s r r r +
P16 2015–06-02 vanB 192 r r r r r r r r r s s s s s r +
P17 2015–06-02 vanA 769 r r r r r r r r r r s s s s r + +
P18 2015–06-02 vanB 192 r r r r r r r r r s s s s s r +
P19 2015–06-07 vanA 769 r r r r r r r r r r s s s s r + +
P20 2015–06-08 vanB 192 r r r r r r r r r s s s s s r +
P21 2015–06-09 vanA 203 r r r r r r r r r r s r s r r +
P22 2015–06-09 vanA 203 r r r r r r r r r r s r s r r +
P23 2015–06-09 vanB 192 r r r r r r r r r s s s s s r
P24 2015–06-09 vanB 192 r r r r r r r r r s s s s s r +
P25 2015–06-16 vanB 192 r r r r r r r r r s s s s s r +
P26 2015–06-16 vanB N/A r r r r r r r r r s s s s s r +
P27 2015–06-17 vanA 203 r r r r r r r r r r s s s r r +
P28 2015–06-19 vanB 192 r r r r r r r r r s s s s s r +
P29 2015–06-23 vanB 192 r r r r r r r r r s s s s s r +
P30 2015–06-23 vanB N/A r r r r r r r r r s s s s s r +
P31 2015–07-01 vanA 192 r r r r r r r r r r s s s r r + +
P32 2015–07-02 vanB 17 r r r r r r r r r s s s s r r +
P33 2015–07-02 vanB 80 r r r r r r r r r s s s s s r +
P34 2015–07-07 vanB 192 r r r r r r r r r s s s s s r +
P35 2015–07-07 vanA 203 r r r r r r r r r r s s s r r + +
P36 2015–07-12 vanB N/A r r r r r r r r r s s s s s r +
P37 2015–07-16 vanB 192 r r r r r r r r r s s s s s r +
P38 2015–07-21 vanB N/A r r r r r r r r r s s s s s r +
P39 2015–07-21 vanB N/A r r r r r r r r r s s s s s r +
P40 2015–07-21 vanB N/A r r r r r r r r r s s s s s r +
P41 2015–07-21 vanB 192 r r r r r r r r r s s s s s r + +
P42 2015–07-21 vanA 203 r r r r r r r r r r s s s r r + +
P43 2015–07-30 vanB N/A r r r r r r r r r s s s s s r +
P44 2015–07-30 vanB N/A r r r r r r r r r s s s s s r + +
P45 2015–07-30 vanA 203 r r r r r r r r r r s s s r r +
P46 2015–08-06 vanB N/A r r r r r r r r r s s s s s r +
P47 2015–08-06 vanB 192 r r r r r r r r r s s s s s r +
P48 2015–08-13 vanB N/A r r r r r r r r r s s s s s r + +
P49 2015–08-20 vanB N/A r r r r r r r r r s s s s s r +
P50 2015–08-31 vanB N/A r r r r r r r r r s s s s s r +
P51 2015–09-02 vanB 80 r r r r r r r r r s i s s s r + +
P52 2015–09-07 vanB N/A r r r r r r r r r s s s s s r + +
P53 2015–10-08 vanB 80 r r r r r r r r r s s s s s r + +
P54 2015–10-19 vanB 80 r r r r r r r r r s s s s s r + +
P55 2015–10-19 vanB N/A r r r r r r r r r s s s s s r +
P56 2015–10-26 vanB 80 r r r r r r r r r s s s s s r +
P57 2015–11-25 vanB N/A r r r r r r r r r r s s s s r +
P58 2015–11-30 vanA 203 r r r r r r r r r r s s s r r
P59 2015–12-21 vanA 203 r r r r r r r r r r s s s r r + +
P60 2015–12-21 vanA 203 r r r r r r r r r r s s s r r + +
Pref 2015–05-15 vanA 192 r r r r r r r r r r s s s r r + +
E1 2015–05-11 vanB 192
E2 2015–05-11 vanB 192
E3 2015–05-11 vanB 192
E4 2015–05-11 vanB 192
E5 2015–05-11 vanB 769
E6 2015–05-11 vanA 192
E7 2015–05-19 vanB 192
E8 2015–06-02 vanB 80
E9 2015–06-02 vanB 192
E10 2015–06-02 vanB 80
E11 2015–06-02 vanB N/A

AMP ampicillin, SAM ampicillin/sulbactam, AX amoxicillin, AMC amoxicillin/clavulanic acid, PRL piperacillin, TPZ piperacillin/tazobactam, IPM imipenem, CIP ciprofloxacin, LEV levofloxacin, CN-HLR gentamicin-high level resistance, S-HLR streptomycin-high level resistance, TEC teicoplanin, QD quinopristin/dalfopristin, TGC tigecyclin, LNZ linezolid, F nitrofurantoin, SXT timetoprim/sulfamethoxazole, MLST Multi Locus Sequence Typing, VRE Vancomycin resistant enterococci

r resistant, s susceptible